Oxygen sensors could soon track your breathing too
NCT ID NCT06633861
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study gathered data from 86 hospital patients to help create an algorithm that estimates breathing rate from oxygen sensor waveforms. Participants wore standard oxygen sensors and a reference capnography device. The goal is to enable breathing monitoring without extra equipment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive way to monitor breathing using standard oxygen sensors, reducing the need for extra equipment.
- What could go wrong
- This is a small, completed data collection study, not a treatment trial. The algorithm may not work accurately in all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
86 people
The number who actually took part.
- Started
-
Sep 2024
- Finished
-
Nov 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult subjects (aged 18 years or older) willing and able to understand and provide written informed consent * Paediatric subjects aged 16 years and older willing and able to understand and provide written informed consent * Paediatric subjects aged approx. 4-16 years and their legal guardians, willing and able to understand and provide written informed consent/assent * Subject weight within intended use of at least one SpO2 sensor under test at time of enrolment (M1191T: adult patients \>50kg, M1196T: adult patients \>40kg, M1192A: paediatric patients 15-50kg) * Willing and able to wear study devices during study procedures * Subject undergoing regular spot-check measurements as per the site's standard of care Exclusion Criteria: * Palliative patients * Critically ill patients with severe physiological instability (NEWS ≥9) * Injury/wounds or physical malformation of sensor application site (i.e. fingers, toes, hands, feet) * Subjects with severe contact allergies to standard adhesives, latex or other materials found in pulse oximetry sensors (self-reported) * Unwillingness or inability to remove coloured nail polish or artificial nails from application site * Nail fungus on application site * Severe dermatitis or hyperkeratosis (e.g. ichthyosis) at sensor application site
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for In-patients assessment of vital signs are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ysbyty Gwynedd Hospital
Wales, Bangor, United Kingdom